Salbutamol
- Generic Name
- Salbutamol
- Brand Names
- Airomir, Airsupra, Combivent, Proair, Proventil, Ventolin
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21NO3
- CAS Number
- 18559-94-9
- Unique Ingredient Identifier
- QF8SVZ843E
- Background
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and...
- Indication
Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known t...
- Associated Conditions
- Asthma, Asthmatic Bronchitis, Bronchial Asthma, Bronchoconstriction, Bronchospasm, Chronic Asthma, Chronic Bronchitis, Cough, Emphysema, Exacerbation of asthma, Exercise-Induced Bronchospasm, Hyperkalemia, Wheezing, Excess mucus or phlegm
- Associated Therapies
- Airway secretion clearance therapy, Bronchodilation
A Multi-Centered Study of the Long-Term Effect of Salmeterol and Albuterol in Cystic Fibrosis
- Conditions
- First Posted Date
- 2000-04-14
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Registration Number
- NCT00005110
- Locations
- 🇺🇸
Division of Allergy and Pulmonary Medicine, St. Louis, Missouri, United States
Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy
- Conditions
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Ohio State University
- Target Recruit Count
- 90
- Registration Number
- NCT00004685
Asthma Clinical Research Network (ACRN)
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- Milton S. Hershey Medical Center
- Registration Number
- NCT00000577
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of California at San Diego, La Jolla, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.